Bernadette M. Connaughton's Insider Trades & SAST Disclosures
Bernadette M. Connaughton's most recent trade in Editas Medicine Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 30, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bernadette M. Connaughton.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Editas Medicine Inc | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Halozyme Therapeutics Inc. | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 8,804 | 8,804 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc. | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 6,501 | 46,787 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Syneos Health Inc - Ordina... | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 4,863 | 14,778 (0%) | 0% | 0 | Class A Common Stock | |
| Halozyme Therapeutics Inc. | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 11,371 | 11,371 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc. | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 8,065 | 40,286 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc. | Bernadette M. Connaughton | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Nov 2022 | 5,998 | 32,221 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Syneos Health Inc - Ordina... | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 2,839 | 9,915 (0%) | 0% | 0 | Class A Common Stock | |
| Editas Medicine Inc | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2021 | 24,732 | 24,732 | - | - | Stock Option (right to buy) | |
| Syneos Health Inc - Ordina... | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 2,364 | 7,076 (0%) | 0% | 0 | Class A Common Stock | |
| Halozyme Therapeutics Inc. | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 5,230 | 32,013 | - | 0 | Restricted Stock Units | |
| Syneos Health Inc - Ordina... | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 62.43 per share. | 27 May 2020 | 2,803 | 4,712 (0%) | 0% | 62.4 | 174,991 | Class A Common Stock |
| Halozyme Therapeutics Inc. | Bernadette M. Connaughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 8,829 | 26,783 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges